Since a new law took effect a year ago, England's National Health Service (NHS) has reimbursed patients on only 18 occasions for "unlicensed" cannabis-based products that have not undergone clinical trials, according to government data. The data - which covers November 2018 through August 2019 - relates only to prescriptions in England. Health-care authorities in England, Scotland, Wales and Northern Ireland operate independently. In the United Kingdom, only Epidiolex, nabilone and Sativex are...
Browse Article Categories
England's health insurance has covered only 18 'unlicensed' cannabis prescriptions
Rate this article
No Comments Yet
Be the first to share what you think!